U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT06967194) titled 'Early Beta Blocker Administration in STEMI Patients With SCAI B Status' on April 28.
Brief Summary: This study is looking at how a medication called beta-blockers (metoprolol) affects patients with a heart attack (STEMI) who are in the cardiac intensive care unit.
When patients are admitted to the unit, they will be randomly placed in one of two groups. One group will get the metoprolol medication, and the other will receive a placebo (a harmless pill that looks like the real medication). All other treatments will be the same for both groups.
During the study, which is 72 hours long, patients will be monitored for blood pressure, h...